KD34

ICD-11 MMS 2026-01

Reactions or intoxications due to drugs administered to fetus or newborn

Description

A group of paediatric substance-induced conditions associated with health interventions applied to a fetus or newborn using pharmaceutical products.

Coding note from above levels

Conditions arising in the perinatal period, even though death or morbidity occurs later, should, as far as possible, be coded to chapter 19, which takes precedence over chapters containing codes for diseases by their anatomical site. For children less than 28 days old, assume that a reported condition developed in the perinatal period, unless the duration is stated and the onset was after the first completed week of life.

Index terms

  • Reactions or intoxications due to drugs administered to fetus or newborn
  • newborn drug intoxication
  • Chloramphenicol toxicity in the newborn
Show allHide
  • Grey baby
  • Grey baby syndrome
  • Grey syndrome
  • Grey syndrome from chloramphenicol administration in newborn
  • Grey syndrome of newborn
  • Aminoglycoside toxicity in the newborn

Excludes

  • KA06.0 – reactions and intoxications from maternal opiates, tranquillizers and other medication
  • KA87.4 – Neonatal hyperbilirubinaemia due to drugs or toxins transmitted from mother
  • KA87.5 – Neonatal hyperbilirubinaemia due to drugs or toxins given to newborn
  • KD35 – Neonatal withdrawal syndrome from maternal use of drugs of addiction
  • KD36 – Withdrawal symptoms from therapeutic use of drugs in newborn

Exclusions from above levels

  • 01 – Certain infectious or parasitic diseases - acquired after birth
  • 02 – Neoplasms
  • 05 – Endocrine, nutritional or metabolic diseases
Show allHide
  • 08 – Certain congenital diseases of the nervous system
  • 20 – Congenital malformations, deformations and chromosomal abnormalities
  • 22 – Injury, poisoning or certain other consequences of external causes
  • 3A10 – Hereditary haemolytic anaemia
  • 4A01.03 – Transient hypogammaglobulinaemia of infancy
  • 9B71.3 – Retinopathy of prematurity
  • BC43 – congenital cardiomyopathy
  • DA93.0 – Paralytic ileus
  • EA50.Z – Pemphigus neonatorum
  • EH40.00 – Cradle cap
  • http://id.who.int/icd/entity/588616678 – Gastroenteritis or colitis of infectious origin
  • http://id.who.int/icd/entity/609214049 – Congenital gonococcal infection

Sibling codes

  • KD30 – Birth depression
  • KD31 – Wide cranial sutures of newborn
  • KD32 – Feeding problems of newborn
  • KD33 – Jittery baby, not elsewhere classified
  • KD35 – Neonatal withdrawal syndrome from maternal use of drugs of addiction
  • KD36 – Withdrawal symptoms from therapeutic use of drugs in newborn
  • KD37 – Exposure to tobacco smoke in the perinatal period
  • KD38 – Meconium staining
  • KD39 – Complications of intrauterine procedures, not elsewhere classified
  • KD3A – Termination of pregnancy, affecting surviving fetus or newborn
  • KD3B – Fetal death, cause not specified
  • KD3C – Vomiting in newborn
  • KD3Y – Other specified disorders originating in the perinatal period

Foundation entity

Reactions or intoxications due to drugs administered to fetus or newborn – http://id.who.int/icd/entity/142627676

Part of: 19: Certain conditions originating in the perinatal period